BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 14579577)

  • 1. Interaction of the GM2 activator protein with sulfated and sialylated glycosphingolipids.
    Hepbildikler ST; Wendeler M; Sandhoff R; Sandhoff K
    Methods Enzymol; 2003; 363():207-22. PubMed ID: 14579577
    [No Abstract]   [Full Text] [Related]  

  • 2. Interaction of GM2 activator protein with glycosphingolipids.
    Li SC; Hama Y; Li YT
    Methods Enzymol; 2003; 363():230-41. PubMed ID: 14579579
    [No Abstract]   [Full Text] [Related]  

  • 3. Synthesis of novel NBD-GM1 and NBD-GM2 for the transfer activity of GM2-activator protein by a FRET-based assay system.
    Schwarzmann G; Wendeler M; Sandhoff K
    Glycobiology; 2005 Dec; 15(12):1302-11. PubMed ID: 16079415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemokines bind to sulfatides as revealed by surface plasmon resonance.
    Sandhoff R; Grieshaber H; Djafarzadeh R; Sijmonsma TP; Proudfoot AE; Handel TM; Wiegandt H; Nelson PJ; Gröne HJ
    Biochim Biophys Acta; 2005 Feb; 1687(1-3):52-63. PubMed ID: 15708353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The enzyme-binding region of human GM2-activator protein.
    Wendeler M; Werth N; Maier T; Schwarzmann G; Kolter T; Schoeniger M; Hoffmann D; Lemm T; Saenger W; Sandhoff K
    FEBS J; 2006 Mar; 273(5):982-91. PubMed ID: 16478472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and identification of nine sulfated glycosphingolipids containing two unique sulfated gangliosides from the African green monkey kidney cells, Verots S3, and their possible metabolic pathways.
    Niimura Y; Ishizuka I
    Glycobiology; 2006 Aug; 16(8):729-35. PubMed ID: 16614164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis for the enzymatic resistance of the GM2 ganglioside.
    Li YT; Li SC; Ishida H; Kiso M; Raimondi L; Bernardi A; Sonnino S
    Methods Enzymol; 2003; 363():242-64. PubMed ID: 14579580
    [No Abstract]   [Full Text] [Related]  

  • 8. Shed gangliosides provide detergent-independent evidence for type-3 glycosynapses.
    Thorne RF; Mhaidat NM; Ralston KJ; Burns GF
    Biochem Biophys Res Commun; 2007 Apr; 356(1):306-11. PubMed ID: 17350595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mistletoe lectin I is a sialic acid-specific lectin with strict preference to gangliosides and glycoproteins with terminal Neu5Ac alpha 2-6Gal beta 1-4GlcNAc residues.
    Müthing J; Meisen I; Bulau P; Langer M; Witthohn K; Lentzen H; Neumann U; Peter-Katalinić J
    Biochemistry; 2004 Mar; 43(11):2996-3007. PubMed ID: 15023051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the GM2-activator protein in the methylotrophic yeast Pichia pastoris, purification, isotopic labeling, and biophysical characterization.
    Wendeler M; Hoernschemeyer J; John M; Werth N; Schoeniger M; Lemm T; Hartmann R; Kessler H; Sandhoff K
    Protein Expr Purif; 2004 Mar; 34(1):147-57. PubMed ID: 14766311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gangliosides as regulators of cell membrane organization and functions.
    Sonnino S; Prinetti A
    Adv Exp Med Biol; 2010; 688():165-84. PubMed ID: 20919654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional role of glycosphingolipids and gangliosides in control of cell adhesion, motility, and growth, through glycosynaptic microdomains.
    Regina Todeschini A; Hakomori SI
    Biochim Biophys Acta; 2008 Mar; 1780(3):421-33. PubMed ID: 17991443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thin-layer chromatography of glycosphingolipids.
    Schnaar RL; Needham LK
    Methods Enzymol; 1994; 230():371-89. PubMed ID: 7511203
    [No Abstract]   [Full Text] [Related]  

  • 14. Regulatory mechanisms of nervous systems with glycosphingolipids.
    Furukawa K; Ohmi Y; Ohkawa Y; Tokuda N; Kondo Y; Tajima O; Furukawa K
    Neurochem Res; 2011 Sep; 36(9):1578-86. PubMed ID: 21562747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation of the GM2 activator protein in a feline model of GM2 gangliosidosis.
    Martin DR; Cox NR; Morrison NE; Kennamer DM; Peck SL; Dodson AN; Gentry AS; Griffin B; Rolsma MD; Baker HJ
    Acta Neuropathol; 2005 Nov; 110(5):443-50. PubMed ID: 16200419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural analysis of mono- and bis-sulfated glycosphingolipids by negative liquid secondary ion mass spectrometry with high- and low-energy collision-induced dissociation.
    Tadano-Aritomi K; Kubo H; Ireland P; Okuda M; Kasama T; Handa S; Ishizuka I
    Carbohydr Res; 1995 Aug; 273(1):41-52. PubMed ID: 7553669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant ganglioside GM2 synthase--expression in insect cells and enzyme assay.
    Wendeler M; Reilaender H; Hoernschemeyer J; Schwarzmann G; Kolter T; Sandhoff K
    Methods Enzymol; 2003; 363():476-89. PubMed ID: 14579597
    [No Abstract]   [Full Text] [Related]  

  • 18. Designation and schematic structure of gangliosides and allied glycosphingolipids.
    Svennerholm L
    Prog Brain Res; 1994; 101():XI-XIV. PubMed ID: 8029441
    [No Abstract]   [Full Text] [Related]  

  • 19. Large scale biosynthesis of ganglioside analogues by RERF-LC-AI cells cultured in HYPERFlask.
    Shimura Y; Suzuki J; Muraoka M; Kasuya MC; Matsuoka K; Hatanaka K
    Prep Biochem Biotechnol; 2012; 42(4):378-92. PubMed ID: 22708814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Abnormal connection of mutant PS1 to glycosphingolipids metabolism].
    Mutoh T; Yano S; Yamamoto H
    Tanpakushitsu Kakusan Koso; 2004 Nov; 49(15 Suppl):2473-8. PubMed ID: 15553004
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.